O ptimal management of stroke and its sequelae has been shown to result in improved patient outcomes and significant cost savings, in large part because the treatment and care of people disabled by stroke are very costly. Over the past 5 years, the Canadian Stroke Strategy has implemented a multipronged approach to encourage and support all provinces and territories in Canada to develop and implement integrated systems of stroke care with the goal of improving quality of care and health outcomes of individuals with stroke. The Canadian Stroke Network encourages the use of the evidence-based Canadian Best Practice Recommendations for Stroke Care, which span the stroke care continuum, from primary prevention to rehabilitation and return to the community for ongoing recovery. 1 A number of these recommendations, if routinely implemented, are expected to be cost-effective. Current evidence suggests that rapid assessment and treatment of patients who present with transient ischemic attack (TIA) or minor stroke reduces the risk of progression to or recurrence of a disabling stroke; moreover, this approach is cost-effective. [2] [3] [4] [5] Similarly, thrombolytic therapy-through the administration of recombinant tissue-type plasminogen activator (tPA) within a 3-hour window from symptom onset-is effective for a subset of patients with stroke 6, 7 and is cost-effective. 8 -11 Providing acute care in organized stroke units is associated with a significant reduction in death, dependency, length of hospital stay, [12] [13] [14] [15] and is also cost-effective. 16 -18 Early homesupported discharge, in which patients are released from the hospital at an earlier point in recovery than would normally occur, and receive intensive rehabilitation in their home by a team of stroke rehabilitation specialists, is associated with a significant reduction in the length of hospital stay, lower incidence of death or dependency, 19 and may be cost-effective. 20 -24 The purpose of this study was to estimate the potential for cost avoidance in Canada from a societal perspective if these 4 aspects of stroke management were provided in a comprehensive and optimal fashion.
Methods

Current Stroke Care in Canada
The following 3 independent data sets were used to provide an overview of current stroke care in Canada, which in turn was used as the base model when assessing the effect of optimizing stroke care: Data from these sources were used to determine the annual number of hospital episodes for ischemic stroke, hemorrhagic stroke, and TIA in Canada, whether the hospital episode was associated with an incident or recurrent stroke or a readmission, average length of stay in the hospital, and hospital discharge disposition. We excluded venous sinus thrombosis. Additional estimates based on these data sources include the annual risk of stroke recurrence, progression after an incident TIA or nonhospitalized stroke to a hospitalized stroke, length of stay in a residential care facility, stroke severity, proportion of patients receiving tPA, and the proportion of patients receiving care in a stroke unit.
The cerebrovascular literature was used to estimate additional base model parameters including years of life lost 25 and quality of life for stroke survivors. 26 See Table 1 and the online-only Data Supplement (http://stroke.ahajournals.org) for additional details and references.
Optimal Stroke Care Model Assumptions
Optimal stroke care was modeled based on the assumption that 80% of patients with a TIA/nonhospitalized stroke would receive rapid assessment and treatment, 10% of hospitalized patients with ischemic stroke would receive tPA, 80% of hospitalized patients with stroke would be cared for in an organized stroke unit, and 37% of hospitalized patients would receive early home-supported discharge.
The major benefits of optimal stroke care include a 70% reduction in progression to a hospitalized stroke after a TIA/nonhospitalized stroke, [2] [3] [4] an 11% reduced risk of dependency after the administration of tPA, 7,27,28 a 21% reduction in average length of stay and 20% reduction in death and dependency associated with care in an organized stroke unit, 12 and a 27% reduction in average length of stay and 26% reduction in death and dependency associated with receiving early home-supported discharge. 19, 29 See Table 2 and the online-only Data Supplement for additional benefits, details, and references.
Determining Unit Costs
The daily cost of residential care in Canada was calculated based on information from Statistics Canada. 30 The cost of an acute care day for patients with ischemic and hemorrhagic stroke was estimated based on data from 2006 -2007 to 2008 -2009 available from the Ontario Case Costing Initiative. 31 Due to higher unit costs in Ontario compared with other provinces (except Alberta), acute care costs from the Ontario Case Costing Initiative were adjusted for each province and a weighted average cost per day obtained. 32 All costs were adjusted to 2010 Canadian dollars using the health and personal care component of the consumer price index. A modified humancapital approach (in which unpaid time is explicitly valued) was used in calculating indirect costs; in this way, a quality-adjusted life-year (QALY) was valued at $42 275 (the average Canadian annual wage rate in 2010) regardless of the patient's age or work status. A weighted (based on the proportion of stroke hospitalizations in each province) average annual Canadian wage rate was calculated and assigned as the value for changes in the number of QALYs lost. 33 A 3% annual discount rate was applied to all future year costs.
Life-years lost were quality-adjusted based on utilities of 0.64, 0.45, and 0.28 for a minor (Rankin score of 0, 1, 2), moderate (Rankin score of 3), or major stroke (Rankin score of 4, 5), respectively. 26 Thus, 1 year of life with a minor stroke would receive a value of 0.64 QALYs.
Model Progression
In modeling the effect of optimizing stroke care in Canada, and the potential for cost avoidance, the initial focus was on enhancing the rapid assessment and treatment of patients with TIA or minor stroke followed by improving rates of thrombolytic therapy for patients with acute ischemic stroke, enhancing access to care in organized stroke units, and finally providing optimal early home-supported discharge services. The impact of each area of focus was built on the assumption that optimal care had been achieved at earlier points in the continuum.
Future Costs Avoided
In projecting costs avoided between 2010 and 2030 in Canada, current age-specific rates for ischemic and hemorrhagic hospital episodes were combined with age-specific population projections. 34 Age-and stroke type-specific average length of stay and pattern of discharge disposition were kept constant. Adjustments in life expectancy were made to take into account the increasing average age of the stroke population over time and an overall increase in life expectancy of the population aged Ն65 years. Costs were inflated by 3% per year. See the online-only Data Supplement for additional details. QALYs lost annually. These stroke admissions used 639 000 acute care days and 4.5 million residential care days annually. In addition, there were approximately 29 300 incident TIA and nonhospitalized (minor) strokes in Canada per year. A total of 7.4% of patients with an ischemic stroke received tPA. The annual risk of recurrence in the 10 years after an incident stroke decreased from 3.64% in the year after an incident stroke to 0.27% after 10 years. A total of 4.14% of patients with an incident TIA or nonhospitalized stroke progressed to a hospitalized stroke within 365 days. The average length of stay in a residential care facility after an ischemic or hemorrhagic stroke was 525 and 570 days, respectively. Twenty-three percent of patients with a stroke received care in a stroke unit across Canada. The proportion of strokes categorized as minor/moderate/major was 54%/21%/25%.
Results
Current Stroke Care in Canada
Optimal Stroke Care Model Results
The potential impact of optimizing delivery of each intervention is outlined in Table 3 . In each case, we assumed a range of magnitude of effect and conducted a sensitivity analysis to determine a "best-case" and "worst-case" scenario. We present estimates of both direct and indirect costs avoided.
Implementing stroke care in a comprehensive and optimal fashion in Canada would decrease the number of hospital episodes for stroke annually by 1062 (or 3.3% of the 32 081 annual hospital episodes). The number of acute care days would decrease by 166 000 (or 25.9% of the 639 000 annual acute care days). The number of residential care days for patients admitted to such facilities after stroke would decrease by 573 000 (or 12.8% of the 4.5 million residential care days). The estimated change in use of acute and residential care translates to a reduction of 432 and 1553 beds, respectively. The number of deaths in hospital would be reduced by 1061 (or 14.9% of the 7111 annual deaths in 
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hospital) and the number of lost QALYs by 10 568 (or 3.7% of the 286 000 QALYs). Total avoidance of costs is estimated at $682 million annually with direct costs at $307 million and indirect costs at $374 million. The most significant contributions to the direct cost avoidance were generated by optimized access to early supported discharge services ($132.9 million) and organized stroke units ($116.8 million). Both of these areas reduce length of stay in the hospital and reduce the risk of admission to a residential care facility after a stroke. The most significant contribution to the indirect cost avoidance was optimized TIA rapid assessment and treatment (representing $269.2 million in avoided indirect costs). Preventing the risk of progression from a TIA/minor stroke to a major stroke requiring hospitalization has a significant impact on the number of QALYs lost. See the online-only Data Supplement for additional details.
For the average patient with stroke in Canada, implementing comprehensive and optimal care is expected to result in a 3.3% reduced risk of acute hospitalization. For hospitalized patients, we estimate reductions in length of stay by 23.4% (from 19.93-15.27 days), rates of death by 12.1% (from 22.5%-19.8%), and rates of discharge to residential care by 9.9% (from 26.2%-23.6%). For hospitalized patients with stroke, direct costs avoided due to reduced hospital and residential care services would be $8191 per patient, whereas the indirect costs avoided due to the reduced likelihood of early death and improved quality of life would be $3277 per patient. For patients with TIA and those not hospitalized with stroke, the direct and indirect costs avoided would be $1524 and $9187 per patient, respectively.
Sensitivity Analysis
The results of sensitivity analyses are summarized in Table 4 . Most changes in individual assumptions modify the direct or indirect cost estimates by Ͻ10%. The 1 exception is the change in indirect costs associated with a reduction in the effectiveness of TIA rapid assessment and treatment services. The base case scenario assumes an effectiveness of 70%, whereas the sensitivity analysis uses a range from 50% to 80%. Using an effectiveness of 50% in terms of reducing the risk of progression to a hospitalized stroke after an incident TIA translates into a 20.3% decrease in the total indirect costs avoided. Of the 4 interventions considered in the model, a TIA rapid assessment and treatment service is the only 1 with the potential to avoid stroke (rather than improve treatment after a stroke); thus, it represents a substantial opportunity for indirect cost avoidance (ie, reductions in morbidity and mortality).
When all assumptions are modified simultaneously to create scenarios at the extremes of the sensitivity spectrum, the overall annual cost avoidance results would increase from $682 to $892 (ϩ30.9%) million in the best case and decrease to a cost avoidance of $488 (Ϫ28.5%) million in the worstcase scenario.
Future Costs Avoided
Between 2010 and 2031, achieving optimal care could reduce the number of hospital episodes for stroke by 35 500, whereas the number of acute and residential care days could decrease by 4.8 and 19.5 million, respectively. The reduction in the number of deaths in the hospital is estimated at 36 800 and the number of lost QALYs at 388 000. Total avoidance of costs is estimated at $32.1 billion with direct costs at $13.8 billion and indirect costs at $18.3 billion (Figure) .
Discussion
Optimizing stroke care in Canada by improving TIA secondary prevention services, increasing administration of tPA, increasing the proportion of care provided in stroke units, and establishing early supported discharge programs is projected to reduce stroke hospitalization episodes by 1062 (3.3%), acute care days by 166 000 (25.9%), residential care days by 573 000 (12.8%), deaths in the hospital by 1061 (14.9%), and QALYs lost by 10 568 (3.7%). Acute and residential care costs would be reduced by $307 million annually, equivalent to an annual reduction or reallocation of 432 acute and 1553 residential care beds. In addition, the reduction in premature deaths and QALYs lost would be associated with an estimated economic cost avoided of $374 million annually.
Between 2010 and 2031, total costs avoided could reach $32.1 billion.
The annual occurrence of a hospitalized stroke, after an incident TIA or nonhospitalized stroke, in this study (4.14%) differs from the 90-day recurrence rate of approximately 10% reported by Rothwell et al. 2 In an effort to capture all recurrent stroke events, the authors followed individual patients for 24 months after the initial visit to their clinic. This level of ascertainment is not possible using administrative data. Instead, the stroke rate was calculated based on patients with incident TIA/minor (nonhospitalized) stroke who were subsequently hospitalized for a stroke. While underestimating the true rate of early recurrence, this approach captures the majority of costs associated with resource use in treating this population. Likewise, changes in the stroke rate associated with provision of optimal care and consequent reductions in hospitalization would generate the majority of avoided costs.
The role of intravenous thrombolysis in an acute ischemic stroke is well established as a cost-effective treatment. 8 -11 However, even with ideal systems of care, many patients with stroke may not be suitable candidates for thrombolysis either because their symptoms are so mild or because delays in presentation are unavoidable. Stroke is a condition that often renders the patient incapable of activating emergency response services in an urgent fashion, and the public is not aware of the necessity of rapid action; thus, patients living alone who have a stroke are rarely treated with thrombolysis because they cannot get to help in time, and witnessed stroke may not be responded to appropriately. Distance to treatment TIA indicates transient ischemic attack; tPA, tissue-type plasminogen activator; QALYs, quality-adjusted life-years. *Eighty percent of patients not receiving optimal care will ultimately receive optimal care. †tPA use will increase from 7.40% of hospitalized patients with ischemic stroke in 2008 -2009 to 10%. ‡Eighty percent of patients not receiving optimal care will ultimately receive optimal care. §Thirty-seven percent of patients will ultimately receive optimal care. in Canada where geography has a direct impact on access to care may be an important limiting factor for a minority of the population. Randomized controlled clinical trials and observational studies of stroke units in their "natural" environment have demonstrated that stroke unit care is highly effective, whether based in large tertiary referral centers or smaller referral hospitals. 12, 14, 15, 35 However, because it is a system or model of care with multiple components, it is often difficult to implement. There are relatively few cost-effectiveness studies relevant to this area, but modeling has suggested that stroke unit care approach is cost-effective. 16 -18 Recent Canadian data suggest that cost avoidance would mostly be generated from reducing the length of stay of hospitalized patients. 15 Because all patients with stroke, including those with hemorrhagic stroke and selected patients with TIA, can benefit from stroke unit care, the greatest cost avoidance would be achieved with the widespread availability of stroke units. In practice, this would mean centralizing stroke care in stroke centers and establishing stroke units in smaller nonreferral institutions, particularly in remote regions where transfer to a specialized stroke center would not be feasible. This effort has begun in hospitals throughout Canada but could be accelerated. Recently published data suggest that the volume of treated patients with stroke and adherence to quality-ofcare criteria through certification can improve stroke care. 36, 37 In this way, stroke care is much like trauma in which the concentration of care in designated hospitals can result in substantial cost avoidance and better outcomes for patients. Cost avoidance benefits will depend on the local medical system such that in other jurisdictions where acute hospitals stays are much shorter than in Canada, stroke unit care may have less of an economic impact.
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The implementation of an early supported discharge approach to stroke care is less well studied in the economic literature. 20 -23 Because bed days are a major driver of acute care costs, and early supported discharge is associated with a reduction in length of stay, the economic benefits may be unique to health systems with longer acute or rehabilitation lengths of stay. Research from Canada does suggest further benefits associated with a reduction in readmissions. 21 Our study is limited in that it is not based on a costeffectiveness approach. That is, the estimated costs of implementing these changes in stroke care in Canada were not calculated or included in a full cost-effectiveness framework. Indeed, to include an estimate of indirect costs, we have placed a value on QALYs lost, a usual output measure in most cost-effectiveness analyses. However, our modeling exercise is based on multiple current and accurate sources of data, which provides an estimate of cost avoidance when applying optimal stroke care in 4 key areas in Canada. By their very nature, these types of studies are limited by the appropriateness of the assumptions made. Sensitivity analyses show a range of benefit and that even using a worst-case scenario, there is still likely to be significant cost avoidance.
Furthermore, primary prevention is a key component of any integrated stroke strategy and, if successful, would result in the avoidance of all resources associated with stroke care identified in our model. Our analysis begins with the assumption that primary prevention has been unsuccessful.
In summary, these analyses suggest that costs of stroke care might be substantially attenuated in Canada and elsewhere with the greater application of known effective treatment modalities focusing on different components of the stroke continuum. The magnitude of potential cost savings over 2 decades could be substantial. Healthcare decisionmakers could use these data to better plan investment in stroke systems of care over the next decade.
